-The Hindu Official secrecy on pandemic policies aggravates a crisis In August 2020, the Modi government constituted the National Expert Group on Vaccine Administration for COVID-19 (NEGVAC) as a nodal agency on all matters related to vaccine administration and rollout. Asked under the Right to Information (RTI) Act for details of the NEGVAC’s meetings, the Health Ministry, which anchors the expert group, replied that it does not know where the concerned documents...

-The Hindu A monthly cash transfer to informal workers will provide them relief and also revive the economy The majority of India’s working population is today reeling from the impact of multiple crises: a health emergency more ferocious than any in independent India; massive job losses and dramatic declines in incomes from work; and significantly increased mass hunger and worsening nutrition. Many failures The Supreme Court on May 13 directed the Centre and the...

-The Hindu Measures on urea, LPG, kerosene to go The Modi government is putting on hold its plans for some key economic reforms Union Finance Minister Arun Jaitley had announced in his maiden Budget last July. These include decontrol of urea prices, fewer subsidised cylinders a year and withdrawal of kerosene from the public distribution system (PDS). Fertilizer Minister Ananth Kumar told The Hindu that the administered price controls for urea would stay. "We...

-The Hindu Only un-electrified households will be entitled to subsidised fuel New Delhi: Attacking the subsidy regime, Union Finance Minister Arun Jaitley has scrapped the supply of subsidised kerosene through the Public Distribution System (PDS). The Centre plans to write to States asking them to provide subsidised kerosene only to un-electrified households. States which have achieved near 100 per cent electrification will be incentivised to become kerosene-free, a Finance Ministry source told...

-The Hindu The current market prices are essentially over and above the actual cost of production - a difference that could run from 100 per cent to 5,600 per cent, depending upon various therapeutic categories In a liberalised market economy, do we need price controls on drugs? Policymakers and the pharmaceutical industry do not think so. They believe that price controls are an inefficient tool that distorts resource allocation, squeezes revenue, reduces...